SCHEMBL5451889

SCHEMBL5451889

CNC(=O)COC(=O)N1CCC(CCCc2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.57
HTT P42858 2/20 0.47
POLB P06746 1/20 0.47
MAOB P27338 1/20 0.46
HDAC1 Q13547 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
SMYD3 Q9H7B4 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
LMNA P02545 2/20 0.42
MAPK1 P28482 2/20 0.42
USP2 O75604 1/20 0.42
TEAD1 P28347 2/20 0.42
RAB9A P51151 1/20 0.42
ENPP2 Q13822 1/20 0.41
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHRM4 P08173 1/20 0.41
SIGMAR1 Q99720 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5451896 0.94 FAAH (0.65) FAAHHTTPOLBMAOBSMYD3
SCHEMBL5453583 0.88 FAAH (0.67) FAAHMAOBHDAC1HDAC8TEAD1
SCHEMBL5455256 0.86 FAAH (0.68) FAAHMEN1KMT2ALMNAENPP2
SCHEMBL5450845 0.85 FAAH (0.58) FAAHHTTHDAC1HDAC8MEN1
SCHEMBL4306303 0.85 MEN1 (0.49) FAAHHTTPOLBHDAC1HDAC8
SCHEMBL5447919 0.84 FAAH (0.56) FAAHENPP2CHRM4
SCHEMBL5447912 0.82 FAAH (0.62) FAAHHTTHDAC1HDAC8MEN1
SCHEMBL5450185 0.82 FAAH (0.77) FAAHMAOBTEAD1ENPP2ALDH1A1
SCHEMBL5449588 0.81 DRD2 (0.51) FAAHHTTPOLBLMNAMAPK1
SCHEMBL1581810 0.80 MAOB (0.53) MAOBHDAC1HDAC8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021405-A1 ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021405-A1 ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS FAAH, FAAH2, HRH2 FAAH 1/4885HTT 1330/4885POLB 2598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.